Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124636302 | 12463630 | 2 | F | 20160822 | 20160614 | 20160825 | PER | US-PFIZER INC-2016266643 | PFIZER | 59.00 | YR | F | Y | 75.30000 | KG | 20160825 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124636302 | 12463630 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | Oral | ONE 300MG TABLET THREE TIMES A DAY | Y | 20882 | 300 | MG | FILM-COATED TABLET | TID | |||||
| 124636302 | 12463630 | 2 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | ONE 600MG TABLET THREE TIMES A DAY | Y | 20882 | 600 | MG | FILM-COATED TABLET | TID | |||||
| 124636302 | 12463630 | 3 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 1/2 600MG IN THE MORNING, 1/2 600MG IN THE AFTERNOON, ONE 600MG IN THE EVENING | Y | 20882 | FILM-COATED TABLET | TID | |||||||
| 124636302 | 12463630 | 4 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 300 MG, 3X/DAY | 20235 | 300 | MG | CAPSULE, HARD | TID | ||||||
| 124636302 | 12463630 | 5 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Oral | 4000 IU, DAILY, TWO 2000IU TABLETS IN EVENING | 0 | 4000 | IU | TABLET | |||||||
| 124636302 | 12463630 | 6 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Oral | ONE PILL ONCE EVERY EVENING, DOSAGE: 2000 PER PILL | 0 | 1 | DF | QD | |||||||
| 124636302 | 12463630 | 7 | C | MEGA RED | 2 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124636302 | 12463630 | 1 | Neuropathy peripheral |
| 124636302 | 12463630 | 4 | Neuropathy peripheral |
| 124636302 | 12463630 | 5 | Vitamin D deficiency |
| 124636302 | 12463630 | 6 | Vitamin B12 abnormal |
| 124636302 | 12463630 | 7 | Supplementation therapy |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124636302 | 12463630 | Condition aggravated | |
| 124636302 | 12463630 | Drug dose omission | |
| 124636302 | 12463630 | Drug ineffective | |
| 124636302 | 12463630 | Eczema | |
| 124636302 | 12463630 | Gait disturbance | |
| 124636302 | 12463630 | Pain | |
| 124636302 | 12463630 | Pruritus | |
| 124636302 | 12463630 | Rash | |
| 124636302 | 12463630 | Rash erythematous |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124636302 | 12463630 | 1 | 2015 | 0 | ||
| 124636302 | 12463630 | 3 | 2016 | 0 |